还是不涨，有什么用_老虎社区_美港股上老虎

2020-11-10

还是不涨，有什么用

5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的 5 只价值股</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":305539637,"tweetId":"305539637","gmtCreate":1605009001929,"gmtModify":1703835718726,"author":{"id":3552780443992615,"idStr":"3552780443992615","authorId":3552780443992615,"authorIdStr":"3552780443992615","name":"woosu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>还是不涨，有什么用</p></body></html>","htmlText":"<html><head></head><body><p>还是不涨，有什么用</p></body></html>","text":"还是不涨，有什么用","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/305539637","repostId":2082869701,"repostType":2,"repost":{"id":"2082869701","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1604935821,"share":"https://www.laohunote.com/m/news/2082869701?lang=zh_CN&edition=full","pubTime":"2020-11-09 23:30","market":"us","language":"en","title":"5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的 5 只价值股</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2082869701","media":"Benzinga Earnings","summary":"What are Value Stocks?\n\nA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.","content":"<p><html><body><h1>What are Value Stocks?</h1> A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.</p><p><blockquote><html><body><h1>什么是价值股？</h1>价值股的定义传统上取决于市场投资者对公司未来增长前景的估值。低市盈率是该公司被低估的良好基础指标，很可能被贴上价值股的标签。</body></html></blockquote></p><p> <h2>Below is a list of notable value stocks in the healthcare sector:</h2> <ol> <li><strong>SELLAS Life Sciences Gr</strong> (NASDAQ:SLS) - P/E: 0.62</li> <li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus Pharmaceuticals</a></strong> (NASDAQ:SUPN) - P/E: 9.78</li> <li><strong>Ocugen</strong> (NASDAQ:OCGN) - P/E: 0.04</li> <li><strong>Oncternal Therapeutics</strong> (NASDAQ:ONCT) - P/E: 4.61</li> <li><strong>Coherus BioSciences</strong> (NASDAQ:CHRS) - P/E: 7.01</li> </ol> SELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote><h2>以下是医疗保健行业著名价值股列表：</h2><ol><li><strong>SELLAS 生命科学 Gr</strong>（纳斯达克股票代码：SLS） - 市盈率：0.62</li><li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus制药</a></strong>（纳斯达克股票代码：SUPN） - 市盈率：9.78</li><li><strong>奥库根</strong>（纳斯达克股票代码：OCGN） - 市盈率：0.04</li><li><strong>内在疗法</strong>（纳斯达克股票代码：ONCT） - 市盈率：4.61</li><li><strong>Coherus生物科学</strong>（纳斯达克股票代码：CHRS） - 市盈率：7.01</li></ol>SELLAS Life Sciences Gr 已被列为价值股。SELLAS Life Sciences Gr 第二季度每股收益为 -0.66，自上季度（第一季度）以来没有变化。SELLAS Life Sciences Gr 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Most recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>最近，Supernus Pharmaceuticals 公布的每股收益为 0.74，而第二季度每股收益为 0.65。Supernus Pharmaceuticals 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Ocugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>Ocugen 公布第三季度每股收益为 -0.02，较第二季度 -0.19 增长 89.47%。Ocugen 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Most recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>最近，Oncternal Therapeutics 报告的每股收益为 -0.22，而第二季度的每股收益为 -0.34。Oncternal Therapeutics 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Coherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>Coherus BioSciences 第三季度的每股收益为 0.47，而第二季度的每股收益为 0.81。Coherus BioSciences 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.</p><p><blockquote>这5只价值股是Benzinga Insights根据量化分析选择的。虽然这种有条不紊的判断过程并不意味着做出最终决定，但我们的技术可以让投资者对该行业有更多的了解。</blockquote></p><p> </body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的 5 只价值股</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Value Stocks To Watch In The Healthcare Sector<blockquote>医疗保健行业值得关注的 5 只价值股</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2020-11-09 23:30</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><html><body><h1>What are Value Stocks?</h1> A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.</p><p><blockquote><html><body><h1>什么是价值股？</h1>价值股的定义传统上取决于市场投资者对公司未来增长前景的估值。低市盈率是该公司被低估的良好基础指标，很可能被贴上价值股的标签。</body></html></blockquote></p><p> <h2>Below is a list of notable value stocks in the healthcare sector:</h2> <ol> <li><strong>SELLAS Life Sciences Gr</strong> (NASDAQ:SLS) - P/E: 0.62</li> <li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus Pharmaceuticals</a></strong> (NASDAQ:SUPN) - P/E: 9.78</li> <li><strong>Ocugen</strong> (NASDAQ:OCGN) - P/E: 0.04</li> <li><strong>Oncternal Therapeutics</strong> (NASDAQ:ONCT) - P/E: 4.61</li> <li><strong>Coherus BioSciences</strong> (NASDAQ:CHRS) - P/E: 7.01</li> </ol> SELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote><h2>以下是医疗保健行业著名价值股列表：</h2><ol><li><strong>SELLAS 生命科学 Gr</strong>（纳斯达克股票代码：SLS） - 市盈率：0.62</li><li><strong><a href=\"https://laohu8.com/S/SUPN\">Supernus制药</a></strong>（纳斯达克股票代码：SUPN） - 市盈率：9.78</li><li><strong>奥库根</strong>（纳斯达克股票代码：OCGN） - 市盈率：0.04</li><li><strong>内在疗法</strong>（纳斯达克股票代码：ONCT） - 市盈率：4.61</li><li><strong>Coherus生物科学</strong>（纳斯达克股票代码：CHRS） - 市盈率：7.01</li></ol>SELLAS Life Sciences Gr 已被列为价值股。SELLAS Life Sciences Gr 第二季度每股收益为 -0.66，自上季度（第一季度）以来没有变化。SELLAS Life Sciences Gr 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Most recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>最近，Supernus Pharmaceuticals 公布的每股收益为 0.74，而第二季度每股收益为 0.65。Supernus Pharmaceuticals 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Ocugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>Ocugen 公布第三季度每股收益为 -0.02，较第二季度 -0.19 增长 89.47%。Ocugen 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Most recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>最近，Oncternal Therapeutics 报告的每股收益为 -0.22，而第二季度的每股收益为 -0.34。Oncternal Therapeutics 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> Coherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.</p><p><blockquote>Coherus BioSciences 第三季度的每股收益为 0.47，而第二季度的每股收益为 0.81。Coherus BioSciences 没有股息收益率，投资者在考虑持有此类股票时应注意这一点。</blockquote></p><p> These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.</p><p><blockquote>这5只价值股是Benzinga Insights根据量化分析选择的。虽然这种有条不紊的判断过程并不意味着做出最终决定，但我们的技术可以让投资者对该行业有更多的了解。</blockquote></p><p> </body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SUPN":"Supernus Pharmaceuticals","SLS":"SELLAS Life Sciences Group Inc.","OCGN":"Ocugen","CHRS":"Coherus Biosciences","ONCT":"Oncternal Therapeutics, Inc."},"source_url":"https://www.benzinga.com/node/18273686","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2082869701","content_text":"What are Value Stocks?\nA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.\nBelow is a list of notable value stocks in the healthcare sector:\n\nSELLAS Life Sciences Gr (NASDAQ:SLS) - P/E: 0.62\nSupernus Pharmaceuticals (NASDAQ:SUPN) - P/E: 9.78\nOcugen (NASDAQ:OCGN) - P/E: 0.04\nOncternal Therapeutics (NASDAQ:ONCT) - P/E: 4.61\nCoherus BioSciences (NASDAQ:CHRS) - P/E: 7.01\n\nSELLAS Life Sciences Gr has been featured as a value stock. SELLAS Life Sciences Gr's Q2 EPS sits at -0.66, which has not changed since last quarter (Q1). SELLAS Life Sciences Gr does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nMost recently, Supernus Pharmaceuticals reported earnings per share at 0.74, whereas in Q2 earnings per share sat at 0.65. Supernus Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nOcugen has reported Q3 earnings per share at -0.02, which has increased by 89.47% compared to Q2, which was -0.19. Ocugen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nMost recently, Oncternal Therapeutics reported earnings per share at -0.22, whereas in Q2 earnings per share sat at -0.34. Oncternal Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nCoherus BioSciences’s earnings per share for Q3 sits at 0.47, whereas in Q2, they were at 0.81. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.\nThese 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.","news_type":1,"symbols_score_info":{"ONCT":0.9,"SUPN":0.9,"SLS":0.9,"OCGN":0.9,"CHRS":0.9}},"isVote":1,"tweetType":1,"viewCount":3772,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/305539637"}